![]() Replacement of failing tunneled hemodialysis catheters through pre-existing subcutaneous tunnels: a comparison of catheter function and infection rates for de novo placements and over-the-wire J Vasc Interv Radiol 998 9:321-7. Duszak R, Haskal ZJ, Thomas-Hawkins C, et al.Estimate of the Risk and Rate of Hemodialysis Catheter-Related On file at Hemosphere, Inc. Scientific Review of Adverse Events in Hemodialysis Grafts. Scientific Review of Adverse Events related to the use of Chronic Hemodialysis Catheters (not including infections). Guideline 1: patient preparation for permanent hemodialysis access. National Kidney Foundation KDOQI clinical practice guidelines for vascular access. Katzman et al, J Vasc Surg, 2009 Comparisons to catheters are from literature review on file. High patency rates: up to 87% 2-year cumulative patency (1,2).Ĭost savings: average savings of 23% per year compared to catheters (3).ġ. ![]() Superior adaptation to dialysis: 1.7 Kt/V: 16% to 32% improvement over catheters (1). It consists of radio-opaque silicone with braided nitinol reinforcement (for resistance to bending and crushing) and a radio-opaque marker at its distal end.įewer infections: infection rate reduced by 69% compared to catheters (1). The HeRO Graft venous outflow component has an ID of 5 mm, an OD of 19F (6.3 mm) and is 40 cm long. The arterial implant component is cannulated using a standard technique according to KDOQI guidelines. The titanium connector attaches the arterial implant component to the venous outflow component. It consists of an ePTFE haemodialysis implant with PTFE ribbing to provide kink resistance in the vicinity of the patented titanium connector. The HeRO Graft arterial implant component has an inner diameter (ID) of 6 mm, an outer diameter (OD) of 7.4 mm and a length of 53 cm, including connector. It consists of two primary components:Ī patented arterial implant component made of ePTFE HeRO Graft is classified by the US FDA as a graft, but differs from a conventional AV graft in that it has no venous anastomosis. HeRO Graft (Hemodialysis Reliable Outflow) is the only fully subcutaneous AV access solution clinically capable of maintaining long-term access in haemodialysis patients with central venous stenosis. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |